The Stomach-Derived Hormone Ghrelin Increases Impulsive Behavior
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Strategies to Increase ß-Cell Mass Expansion
This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents ................................................................................................. -
VU Research Portal
VU Research Portal Genetic architecture and behavioral analysis of attention and impulsivity Loos, M. 2012 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Loos, M. (2012). Genetic architecture and behavioral analysis of attention and impulsivity. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 28. Sep. 2021 Genetic architecture and behavioral analysis of attention and impulsivity Maarten Loos 1 About the thesis The work described in this thesis was performed at the Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands. This work was in part funded by the Dutch Neuro-Bsik Mouse Phenomics consortium. The Neuro-Bsik Mouse Phenomics consortium was supported by grant BSIK 03053 from SenterNovem (The Netherlands). -
Richard P. Ebstein
February 2020 Richard P. Ebstein Professor: C2BEF (China Center for Behavior Economics and Finance), Sourthwestern University of Finance and Economics, Chengdu, China Professor: Zhejiang University of Technology, College of Economics and Management DEGREES/DIPLOMAS/PROFESSIONAL QUALIFICATION 1963 BSc Union College, Schenectady, New York 1965 MS Yale University, New Haven 1968 PhD Yale University, New Haven PREVIOUS EMPLOYMENT 1968 1972 Lecturer, Hebrew University, Rehovot 1972 1973 Assistant Professor, New York University Medical Center 1972 1974 Assistant Research Scientist, New York University Medical Center 1974 1982 Senior Scientist, Herzog-Ezrat Nashim Hospital 1980 1981 Visiting Expert, National Institutes of Health, Bethesda 1982 2010 Director of Research & Clinical Lab, Sarah Herzog-(Ezrath Nashim) Hospital 1991 1992 DAAD Fellow, Dept of Neurochemistry, Munich, Germany 1997 2002 Professor (Chaver-Adjunct), Ben-Gurion University 2001 2002 Visiting Professor, Hebrew University 2002 2010 Professor, Hebrew University 2010 2018 Professor, National University of Singapore CITATION ANALYSIS All Since 2014 Citations 28076 11207 h-index 88 53 i10-index 323 177 PUBLICATIONS Relating to Behavioral and Biological Economics and the Social Sciences 1. Y. Huang et al., “Successful aging, cognitive function, socioeconomic status, and leukocyte telomere length,” Psychoneuroendocrinology, vol. 103, pp. 180–187, 2019. 2. Zhong S, Shalev I, Koh D, Ebstein RP, Chew SH. Competitiveness and stress. Int Econ Rev (Philadelphia). 2018;59(3):1263-1281. 3. Yim O-S, Zhang X, Shalev I, Monakhov M, Zhong S, Hsu M, et al. Delay discounting, genetic sensitivity, and leukocyte telomere length. Proc Natl Acad Sci U S A. 2016;113(10). 4. Shen Q, Teo M, Winter E, Hart E, Chew SH, Ebstein RP. -
Brown Adipose Tissue Is Associated with Systemic Concentrations of Peptides Secreted from the Gastrointestinal System and Involv
177:1 M Chondronikola and others BAT and GI-secreted peptides 177:1 33–40 Clinical Study Brown adipose tissue is associated with systemic concentrations of peptides secreted from the gastrointestinal system and involved in appetite regulation Maria Chondronikola1,2,3,4, Craig Porter1,5, Ioannis Malagaris1,2, Aikaterini A Nella1,6 and Labros S Sidossis1,2,4,5,7 1Metabolism Unit, Shriners Hospitals for Children-Galveston, Galveston, Texas, USA, 2Division of Rehabilitation Sciences, Department of Nutrition and Metabolism, University of Texas Medical Branch, Galveston, Texas, USA, 3Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri, USA, 4Department of Nutrition and Dietetics, Harokopio University, Athens, Greece, Correspondence 5Department of Surgery, 6Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas Medical should be addressed Branch, Galveston, Texas, USA, and 7Department of Kinesiology and Health, Rutgers University, New Brunswick, to L S Sidossis New Jersey, USA Email [email protected] Abstract Objective: Brown adipose tissue (BAT) has been proposed as a potential therapeutic target against obesity and its related metabolic conditions. Data from studies in rodents support a cross talk between BAT and other distal tissues. The relation between BAT and peptide hormones secreted from the gastrointestinal system (GI) and involved in appetite regulation is not known in humans. Design: We studied 18 men during thermoneutral conditions and mild non-shivering cold exposure (CE). Methods: 2-Deoxy-2-(18F)fluoro-D-glucose positron emission tomography-computed tomography scans were conducted after mild cold to measure BAT volume. Fasting serum concentration of GI-secreted peptides and peptides involved in European Journal European of Endocrinology appetite regulation were measured during thermoneutral conditions and mild CE. -
Expression of Dopamine-Related Genes in Four Human Brain Regions
brain sciences Article Expression of Dopamine-Related Genes in Four Human Brain Regions Ansley Grimes Stanfill 1,* and Xueyuan Cao 2 1 Associate Professor and Associate Dean of Research, College of Nursing, University of Tennessee Health Science Center, Memphis, TN 38163, USA 2 Assistant Professor, College of Nursing, University of Tennessee Health Science Center, Memphis, TN 38163, USA; [email protected] * Correspondence: astanfi[email protected] Received: 1 July 2020; Accepted: 14 August 2020; Published: 18 August 2020 Abstract: A better understanding of dopaminergic gene expression will inform future treatment options for many different neurologic and psychiatric conditions. Here, we utilized the National Institutes of Health’s Genotype-Tissue Expression project (GTEx) dataset to investigate genotype by expression associations in seven dopamine pathway genes (ANKK1, DBH, DRD1, DRD2, DRD3, DRD5, and SLC6A3) in and across four human brain tissues (prefrontal cortex, nucleus accumbens, substantia nigra, and hippocampus). We found that age alters expression of DRD1 in the nucleus accumbens and prefrontal cortex, DRD3 in the nucleus accumbens, and DRD5 in the hippocampus and prefrontal cortex. Sex was associated with expression of DRD5 in substantia nigra and hippocampus, and SLC6A3 in substantia nigra. We found that three linkage disequilibrium blocks of SNPs, all located in DRD2, were associated with alterations in expression across all four tissues. These demographic characteristic associations and these variants should be further investigated for use in screening, diagnosis, and future treatment of neurological and psychiatric conditions. Keywords: dopamine; dopamine receptors; mesocortical; mesolimbic; nigrostrial; prefrontal cortex; nucleus accumbens; substantia nigra; hippocampus; human 1. Introduction Multiple neurological and psychiatric diseases result from alterations in the production, degradation, or improper signaling of dopamine in the brain. -
Ghrelin, the GO Hormone.Indd
Ghrelin, the “Go” Hormone by Ted Kyle, RPh, MBA, and William Hignett What if we could, for one day, create our bodies and Interesting Fact change them as we please to improve our physical nature? How would we enhance our strengths and What exactly is meant by address what we see as problems? How would we change our bodies and minds to alleviate stress, anxiety saying ghrelin is the hunger and physical problems? Related to weight, we would probably make it easier and very straightforward to lose hormone? pounds and fat and to keep the weight off our bodies. Th e ghrelin hormone, discovered in 1999, is released If we had this power, we might consider simplifying primarily from cells in the stomach and travels to the hormonal actions that fuel and curb hunger so these brain. Th ere, it interacts with both the hypothalamus actions are clear-cut and we comprehend exactly how (the brain’s physiological eating center) and the to lose weight. In fact, in real life, two hormones do brain’s pleasure centers to arouse hunger. appear to be this direct in their actions on eating and weight. Ghrelin (grell-in) is the hunger hormone and Th roughout the course of a day, ghrelin levels leptin is the stop appetite hormone. Many believe that naturally change dramatically, rising steeply before the actions of these “go and stop” appetite hormones a meal and then plummeting after eating. Ghrelin are straightforward, and that one is bad and the other stimulates the brain, which leads to an increase in is good. -
Circulating Ghrelin Levels in Girls with Central Precocious Puberty Are
European Journal of Endocrinology (2007) 156 99–103 ISSN 0804-4643 CLINICAL STUDY Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog Claudio Maffeis1, Roberto Franceschi1, Paolo Moghetti2, Marta Camilot1, Silvana Lauriola1 and Luciano Tato`1 1Department of Mother and Child, Biology-Genetics, Section of Pediatrics and 2Department of Biomedical and Surgical Sciences, Endocrinology Unit, University of Verona, P.le L.A. Scuro, 10, 37134 Verona, Italy (Correspondence should be addressed to C Maffeis; Email: [email protected]) Abstract Decreased levels of ghrelin have been measured in growing children during puberty. No data are available for girls with central precocious puberty (CPP). Aims: To explore ghrelin changes before, during, and after GnRH analog treatment in girls with CPP. Subjects and methods: A sample of 20 Caucasian girls (8.08G0.65 years of age) with CPP was recruited. Height and weight, bone age, LH, FSH, 17b estradiol (E2), and ghrelin were measured before starting treatment with GnRH analog, 18 months after therapy began and again 6 months after therapy discontinuation. Results: LH and E2 serum levels decreased significantly during treatment (2.45G2.03 vs 0.67G 0.49 UI/l, P!0.01 and 28.17G9.7 vs 15 pmol/l, P!0.01 respectively), returning to baseline levels after the discontinuation of therapy (4.75G1.66 UI/l and 29.23G6.99 pmol/l respectively). LH peaked following LHRH stimulation significantly (P!0.01) decreased during treatment (24.45G 14.17 vs 1.3G0.18 UI/l) and then increased after therapy discontinuation (12.58G6.09, P!0.01). -
Rapid Sensing of Circulating Ghrelin by Hypothalamic Appetite-Modifying Neurons
Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons Marie Schaeffera,b,c,1, Fanny Langletd,e,1, Chrystel Lafonta,b,c, François Molinoa,b,c,f, David J. Hodsona,b,c,2, Thomas Rouxg, Laurent Lamarqueg, Pascal Verdiéh, Emmanuel Bourrierg, Bénédicte Dehouckd,e,i, Jean-Louis Banèresh, Jean Martinezh, Pierre-François Mérya,b,c, Jacky Marieh, Eric Trinquetg, Jean-Alain Fehrentzh, Vincent Prévotd,e, and Patrice Mollarda,b,c,3 aCentre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France; bInstitut National de la Santé et de la Recherche Médicale, Unité 661, F-34000 Montpellier, France; cUniversities of Montpellier 1 and 2, Unité Mixte de Recherche 5203, F-34000 Montpellier, France; dInstitut National de la Santé et de la Recherche Médicale, Jean-Pierre Aubert Research Center, Unité 837, F-59000 Lille, France; eFaculté de Médecine, Université Droit et Santé de Lille, F-59000 Lille, France; fUniversity Montpellier 2, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5221, Laboratoire Charles Coulomb, F-34095 Montpellier, France; gCisbio Bioassays, 30200 Codolet, France; hCentre National de la Recherche Scientifique, Unité Mixte de Recherche 5247, Institut des Biomolécules Max Mousseron, Faculty of Pharmacy, Universities of Montpellier 1 and 2, F-34093 Montpellier Cedex 5, France; and iUniversité d’Artois, F-62800 Liévin, France Edited* by Tomas G. M. Hökfelt, Karolinska Institutet, Stockholm, Sweden, and approved December 7, 2012 (received for review July 24, 2012) To maintain homeostasis, hypothalamic neurons in the arcuate in real time the extravasation of fluorescent molecules (14). Ghrelin nucleus must dynamically sense and integrate a multitude of was chosen as a candidate hormone because its acute effects upon peripheral signals. -
Anorexia Nervosa: a Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan
Int. J. Med. Sci. 2011, 8 679 Ivyspring International Publisher International Journal of Medical Sciences 2011; 8(8):679-703 Review Anorexia Nervosa: A Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan Mahatma Gandhi Mission’s Medical College, Aurangabad, Maharashtra, India Corresponding author: [email protected] or [email protected]. 1345 Daniel Creek Road, Mississau- ga, Ontario, L5V1V3, Canada. © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2011.05.03; Accepted: 2011.09.19; Published: 2011.10.22 Abstract The roles of corticotrophin-releasing factor (CRF), opioid peptides, leptin and ghrelin in anorexia nervosa (AN) were discussed in this paper. CRF is the key mediator of the hypo- thalamo-pituitary-adrenal (HPA) axis and also acts at various other parts of the brain, such as the limbic system and the peripheral nervous system. CRF action is mediated through the CRF1 and CRF2 receptors, with both HPA axis-dependent and HPA axis-independent ac- tions, where the latter shows nil involvement of the autonomic nervous system. CRF1 re- ceptors mediate both the HPA axis-dependent and independent pathways through CRF, while the CRF2 receptors exclusively mediate the HPA axis-independent pathways through uro- cortin. Opioid peptides are involved in the adaptation and regulation of energy intake and utilization through reward-related behavior. Opioids play a role in the addictive component of AN, as described by the “auto-addiction opioids theory”. -
Revisão from Growth Hormone-Releasing
From Growth Hormone-Releasing Peptides to Ghrelin: Discovery of New Modulators of GH Secretion revisão ABSTRACT Ana Maria J. Lengyel Growth hormone (GH)-releasing hormone and somatostatin modulate GH secretion. A third mechanism has been discovered in the last decade, involving the action of GH secretagogues. Ghrelin is a new acy- lated peptide produced mainly by the stomach, but also synthesized in the hypothalamus. This compound increases both GH release and food intake. The relative roles of hypothalamic and circulating ghrelin on GH secretion are still unknown. Endogenous ghrelin might amplify the basic pattern of GH secretion, optimizing somatotroph responsiveness to GH- releasing hormone. This peptide activates multiple interdependent intra- cellular pathways at the somatotroph, involving protein kinase C, protein kinase A and extracellular calcium systems. However, as ghrelin induces a greater release of GH in vivo, its main site of action is the hypothala- mus. In this paper we review the available data on the discovery of ghre- lin, the mechanisms of action and possible physiological roles of GH sec- retagogues and ghrelin on GH secretion, and, finally, the regulation of GH release in man after intravenous administration of these peptides. (Arq Bras Endocrinol Metab 2006;50/1:17-24) Keywords: Ghrelin; GH; Growth hormone secretagogues; GHS RESUMO Dos Peptídeos Liberadores do Hormônio de Crescimento (HC) à Ghreli- Division of Endocrinology, Federal na: Descoberta de Novos Moduladores da Secreção de HC University of São Paulo A secreção de hormônio de crescimento (HC) é modulada pelo hor- (UNIFESP/EPM), mônio liberador de HC e pela somatostatina. Na ultima década foi descoberto um terceiro mecanismo de controle, envolvendo os secre- São Paulo, Brazil. -
And Des-Acyl Ghrelin
European Journal of Endocrinology (2012) 167 601–608 ISSN 0804-4643 REVIEW MECHANISMS IN ENDOCRINOLOGY Ghrelin: the differences between acyl- and des-acyl ghrelin Patric J D Delhanty, Sebastian J Neggers and Aart J van der Lely Department of Medicine, Erasmus University MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands (Correspondence should be addressed to A J van der Lely; Email: [email protected]) Abstract Des-acyl ghrelin (DAG) is one of the three preproghrelin gene-encoded peptides. Compared with ghrelin and obestatin, it has not received the attention it deserves. DAG has long been considered an inert degradation product of acyl ghrelin (AG). Recent evidence, however, indicates that DAG behaves like a separate hormone. DAG can act together with AG, can antagonize AG, and seems to have AG-independent effects. Therefore, it is believed that DAG must activate its own receptor and that it may also interact with AG at this receptor. Of potential clinical importance is that an increasing number of studies suggest that DAG might be a functional inhibitor of ghrelin and that DAG can suppress ghrelin levels in humans. Therefore, DAG or DAG analogs might be good candidates for future treatment of metabolic disorders or other conditions in which antagonism of AG actions could be beneficial, such as diabetes, obesity, and Prader–Willi syndrome. European Journal of Endocrinology 167 601–608 Introduction We describe the properties of DAG not only as a functional antagonist of AG but also as a strong It is now more than 12 years since ghrelin was identified inhibitor of AG serum levels in vivo in animals and as the ligand of the GH secretagogue receptor type 1a men. -
Growth Hormone-Releasing Hormone As an Agonist of the Ghrelin Receptor GHS-R1a
Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a Felipe F. Casanuevaa,b,c,1, Jesus P. Camin˜ aa,c, Marcos C. Carreirac, Yolanda Pazosa,c, Jozsef L. Vargad, and Andrew V. Schallyd aLaboratory of Molecular and Cellular Endocrinology, Research Area, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain; bDepartment of Medicine, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain; cCIBER de Fisiopatología de la Obesidad y Nutricio´n (CB06/03), Instituto de Salud Carlos III, Spain; and dVeterans Affairs Medical Center, 1201 NW 16th Street, Research Service (151), and University of Miami Miller School of Medicine, Departments of Pathology and Medicine, Division of Hematology and Oncology, Miami, FL 33125 Contributed by Andrew V. Schally, November 17, 2008 (sent for review March 27, 2008) Ghrelin synergizes with growth hormone-releasing hormone on the observation that GH-releasing action of GHS is blunted (GHRH) to potentiate growth hormone (GH) response through a in the presence of GHRH receptor antagonists (11). An in- mechanism not yet fully characterized. This study was conducted creased release of GHRH into hypophyseal portal blood after to analyze the role of GHRH as a potential ligand of the ghrelin GHS administration has also been shown in sheep (12). Fur- receptor, GHS-R1a. The results show that hGHRH(1–29)NH2 (GHRH) thermore, the requirement of a functional GHRH system for induces a dose-dependent calcium mobilization in HEK 293 cells GHS was observed in patients with GHRH receptor deficiency stably transfected with GHS-R1a an effect not observed in wild- who showed a selective absence of GH response to GHS (13).